4-(2-(2,5-DICHLOROPHENYL)DIAZENYL)-N-(4-((4-(((4-(2-(2,5-DICHLOROPHENYL)DIAZENYL)-3-HYDROXY-2-NAPHTHALENYL)CARBONYL)AMINO)BENZOYL)AMINO)PHENYL)-3-HYDROXY-2-NAPHTHALENECARBOXAMIDE
UNII MK7EA3A75Q
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(2-(2,5-dichlorophenyl)diazenyl)-n-(4-((4-(((4-(2-(2,5-dichlorophenyl)diazenyl)-3-hydroxy-2-naphthalenyl)carbonyl)amino)benzoyl)amino)phenyl)-3-hydroxy-2-naphthalenecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MK7EA3A75Q.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 72927-73-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C47H29Cl4N7O5 KBJVUVWQWIQQPG-NCCSDIRBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(2-(2,5-dichlorophenyl)diazenyl)-n-(4-((4-(((4-(2-(2,5-dichlorophenyl)diazenyl)-3-hydroxy-2-naphthalenyl)carbonyl)amino)benzoyl)amino)phenyl)-3-hydroxy-2-naphthalenecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.